|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
06-25-2010, 10:46 PM
|
|||
|
|||
Radium-223 Shows Early Promise In Prostate Cancer Patients With Bone Metastases
CHICAGO - Investigators are reporting favorable results in a phase I pharmacokinetic and biodistribution study in men with bone metastases resulting from castration-resistant prostate cancer (CRPC) who received escalating doses of radium-223. The findings were released at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO). Jorge A. Carrasquillo, MD, with Memorial Sloan ...
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Cancer drug olaparib shows early promise | cancerfr | Pancreatic Cancer | 0 | 07-19-2010 06:41 PM |
| Cancer drug olaparib shows early promise | cancerfr | Ovarian Cancer | 0 | 07-19-2010 06:41 PM |
| Lung cancer drug shows big promise in early tests | cancerfr | Lung Cancer | 0 | 06-09-2010 10:27 PM |
| Radium-223 Chloride (Alpharadin) Shows Potential In Tough-To-Treat Prostate Cancer | cancerfr | Bone Cancer | 0 | 06-09-2010 10:27 PM |
| Early ovarian cancer screening shows promise | cancerfr | Ovarian Cancer | 0 | 05-23-2010 08:01 PM |
Linear Mode
